-
"Diversity, Equity and Inclusion" Page Renewal
Introducing Eisai DE&I: Now and the Future
Learn more
"Diversity, Equity and Inclusion" Page Renewal
Introducing Eisai DE&I: Now and the Future
-
Looking Back on 10 Years Since the Commencement of Free Provision of DEC Tablets
Eisai Staff in Charge Talks About Overcoming Challenges on the Uneven Road by Building Trust in Global Partnerships
Looking Back on 10 Years Since the Commencement of Free Provision of DEC Tablets
-
Scientists Discuss the Development of a New Treatment for the Elimination of Mycetoma
Scientists Discuss the Development of a New Treatment for the Elimination of Mycetoma
-
New Innovation Page Launch
-
April 24, 2024
-
April 17, 2024
-
April 17, 2024
-
April 11, 2024
EISAI SUPPORTS RELIEF EFFORTS FOR THE EARTHQUAKE OF THE EAST COAST OF TAIWAN
-
April 2, 2024
-
March 27, 2024
-
March 11, 2024
-
March 7, 2024
-
February 7, 2024
-
February 6, 2024
IR “Third Quarter Financial Report for the Fiscal Year Ending March 31, 2024”
-
April 8, 2024
-
October 13, 2023
-
March 9, 2023
Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties
-
February 17, 2023
EISAI SUPPORTS RELIEF EFFORTS FOR EARTHQUAKE IN TURKEY AND SYRIA
-
July 15, 2022
Notification Regarding U.S. Research and Development Subsidiary
Sustainability
30 countries 2.28 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of March 2024)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries